Nippon Shinyaku (4516) · FactAdvanced
Inclusion of 北京艾努愛世医薬科技有限公司 in the scope of consolidation
First written in FY2022-Q2. 2 of 3 entries say "Advanced", first in FY2022-Q3. Latest entry: FY2023.
3entries
3years
0from disclosures
How it moved
Same theme, other companies
Expansion of the scope of consolidation through the establishment and consolidation of new subsidiariesA theme 200 companies write about · 0 as a headwind · 135 as a tailwind
36 other companies' latest entry also says "Advanced".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 168 companies compared. The sentences above are computed from all 168.Comparing 200 of the theme's 243 threads.Full recordFilings, disclosures and news, newest first
- FY2023AdvancedAnnual report
「In China, 北京艾努愛世医薬科技有限公司 provides local business support, while 天津艾努愛世医薬有限公司 serves as a sales base.」
The Company clarified the division of roles for its Chinese subsidiaries, with the Beijing entity operating as a business support base and the Tianjin entity as a sales base. - FY2022-Q3AdvancedAnnual report
「In addition, from the current third-quarter consolidated accounting period, 天津艾努愛世医薬有限公司 has been included in the scope of consolidation following its establishment as a new company.」
Following the establishment of the Beijing local subsidiary, 天津艾努愛世医薬有限公司 was newly established and included in the scope of consolidation from the current third-quarter consolidated accounting period. - FY2022-Q2First statedAnnual report
「From the current second-quarter consolidated accounting period, 北京艾努愛世医薬科技有限公司 has been included in the scope of consolidation following its establishment as a new company.」
北京艾努愛世医薬科技有限公司 was newly established and included in the scope of consolidation from the second-quarter consolidated accounting period ended 30 September 2021.